EFEM
IPXL

Eos Focused Equity Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Eos Focused Equity Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-48,714
Closed -$784K – 32
2017
Q2 		$784K Buy
+48,714
New +$720K 0.89% 29

Other funds holding IPXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Eos Focused Equity Management's IPXL Position: Q3 2017 in Review

Eos Focused Equity Management sold out of Impax Laboratories, Inc. (IPXL) in Q3 2017, closing a stake of 48,714 shares — an estimated $784K sold.

Eos Focused Equity Management first reported a position in IPXL in Q2 2017 and held it in 1 quarter. The position peaked at $784K in Q2 2017. 189 funds tracked by Wall St. Rank hold IPXL as of Q3 2017.

  • Eos Focused Equity Management reported no remaining Impax Laboratories, Inc. position as of Q3 2017 after selling out during the quarter.
  • Eos Focused Equity Management sold 48,714 Impax Laboratories, Inc. shares in Q3 2017, an estimated $784K.
  • Eos Focused Equity Management first reported a position in Impax Laboratories, Inc. in Q2 2017 and held it in 1 quarter.
  • Eos Focused Equity Management's Impax Laboratories, Inc. position peaked at $784K in Q2 2017.
  • 189 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2017.

Based on Eos Focused Equity Management's 13F filing for Q3 2017, filed 9 Nov 2017.